Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
The Pending NDC and Barcode Rule: Dispenser Perspectives
With less than six months before the Food and Drug Administration (FDA) anticipates posting an amendment to its National Drug Code (NDC),1 supply chain partners are preparing for this immense change. HDA is continuing dialogue around this impactful regulation — that could cost wholesale distributors hundreds of millions of dollars to implement and maintain.
In this next installment of our series assessing supply chain sector comments, we review feedback from dispenser trade groups and other community members.
HDA Fosters DSCSA Learning and Collaboration Through Recent Traceability Seminar and New Survey Findings
Since helping secure passage of the Drug Supply Chain Security Act (DSCSA) in 2013, HDA has championed industry readiness, stakeholder collaboration and trading partner education around traceability implementation. With the compliance deadline now 13 months away, HDA and the HDA Foundation continued these efforts by hosting the annual Traceability Seminar and releasing the Serialization Readiness Survey and EPCIS Implementation Benchmarking Survey. These educational offerings gauge sector progress toward interoperability and help coalesce supply chain partners to align on critical next steps for compliance.
HDA Recognizes Supply Chain Innovation, Leadership Through 2025 Distribution Management Awards
In early March, the Healthcare Distribution Alliance (HDA) honored several industry leaders and innovators as part of the association’s annual Distribution Management Conference and Expo in Tampa, Florida.